ASX - Delayed Quote AUD

Austco Healthcare Limited (AHC.AX)

Compare
0.2750 -0.0050 (-1.79%)
At close: December 27 at 4:10:49 PM GMT+11
Loading Chart for AHC.AX
DELL
  • Previous Close 0.2800
  • Open 0.2700
  • Bid 0.2700 x --
  • Ask 0.2750 x --
  • Day's Range 0.2700 - 0.2750
  • 52 Week Range 0.1750 - 0.2800
  • Volume 115,056
  • Avg. Volume 348,676
  • Market Cap (intraday) 100.117M
  • Beta (5Y Monthly) 0.73
  • PE Ratio (TTM) 13.75
  • EPS (TTM) 0.0200
  • Earnings Date Feb 24, 2025 - Feb 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Mar 2, 2023
  • 1y Target Est --

Austco Healthcare Limited, together with its subsidiaries, operates as provider of healthcare communication solutions in Australia, New Zealand, Asia, Europe, and North America. The company offers Tacera, an IP nurse call and clinical communications platform; Medicom, a solution for nurse call system; Pulse Mobile which allows staff to manage nurse call functions on the go and trigger workflows remotely; Built-in RTLS, a nurse call platform; enterprise reporting; and integration services. The company was formerly known as Azure Healthcare Limited and changed its name to Austco Healthcare Limited in November 2020. Austco Healthcare Limited was founded in 1986 and is headquartered in Port Melbourne, Australia.

austcohealthcare.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: AHC.AX

View More

Performance Overview: AHC.AX

Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AHC.AX
37.50%
S&P/ASX 200 [XJO]
8.84%

1-Year Return

AHC.AX
41.03%
S&P/ASX 200 [XJO]
9.27%

3-Year Return

AHC.AX
90.69%
S&P/ASX 200 [XJO]
11.34%

5-Year Return

AHC.AX
210.90%
S&P/ASX 200 [XJO]
21.11%

Compare To: AHC.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AHC.AX

View More

Valuation Measures

As of 12/27/2024
  • Market Cap

    100.12M

  • Enterprise Value

    88.34M

  • Trailing P/E

    12.01

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.46

  • Price/Book (mrq)

    2.26

  • Enterprise Value/Revenue

    1.52

  • Enterprise Value/EBITDA

    11.03

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.17%

  • Return on Assets (ttm)

    7.36%

  • Return on Equity (ttm)

    20.40%

  • Revenue (ttm)

    58.15M

  • Net Income Avi to Common (ttm)

    7.08M

  • Diluted EPS (ttm)

    0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.56M

  • Total Debt/Equity (mrq)

    4.01%

  • Levered Free Cash Flow (ttm)

    4.78M

Research Analysis: AHC.AX

View More

People Also Watch